Grants per year
Personal profile
Research Interests
I am dedicated to providing the high-quality and compassionate care for patients with breast cancer. I am interested in clinical research with a focus on developing clinical trials of novel agents for the treatment of all stages of breast cancer and investigating biomarkers to guide therapy decisions.
Training Experience
| 2014 | Residency, Northwestern University, McGaw Medical Center |
| 2018 | Fellowship, Northwestern University, McGaw Medical Center |
Education/Academic qualification
MD, Northwestern University Feinberg School of Medicine
… → 2011
Fingerprint Dive into the research topics where Ami N Shah is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Breast Neoplasms
Medicine & Life Sciences
Heart Failure
Medicine & Life Sciences
Triple Negative Breast Neoplasms
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Registries
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Alveolar Rhabdomyosarcoma
Medicine & Life Sciences
Hospitalization
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2019 2022
- 1 Active
Prot #ALT-002-SRE-01: A Phase I/II Dose Escalation Study of AP-002 In Patients with Advanced or Recurrent Solid Tumors
12/9/19 → 12/9/22
Project: Research project
Research Output 2011 2019
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
Davis, A. A., Zhang, Q., Gerratana, L., Shah, A. N., Zhan, Y., Qiang, W., Finkelman, B. S., Flaum, L., Behdad, A., Gradishar, W. J., Platanias, L. C. & Cristofanilli, M., Dec 4 2019, In : Breast Cancer Research. 21, 1, 137.Research output: Contribution to journal › Article
Open Access
Circulating Neoplastic Cells
Breast Neoplasms
DNA
Neoplasms
Nonparametric Statistics
1
Citation
(Scopus)
Emerging Role of Genomics and Cell-Free DNA in Breast Cancer
Gerratana, L., Davis, A. A., Shah, A. N., Lin, C., Corvaja, C. & Cristofanilli, M., Aug 1 2019, In : Current treatment options in oncology. 20, 8, 68.Research output: Contribution to journal › Review article
Genomics
Breast Neoplasms
Precision Medicine
DNA
Neoplasms
Inhibitors of Tumor Angiogenesis
Shah, AN. & Gradishar, WJ., 2019, Cancer Chemotherapy, Immunotherapy, and Biotherapy: Principles and Practice, 6th edition. Chabner, B. & Longo, DL. (eds.). Philadelphia: Wolters KluwerResearch output: Chapter in Book/Report/Conference proceeding › Chapter
3
Citations
(Scopus)
Adjuvant Anthracyclines in Breast Cancer: What Is Their Role?
Shah, A. N. & Gradishar, W. J., Aug 17 2018, In : The oncologist.Research output: Contribution to journal › Article
Anthracyclines
Breast Neoplasms
Cyclophosphamide
Therapeutics
Lymph Nodes
5
Citations
(Scopus)
Anaplastic lymphoma kinase mutation (ALK F1174C) in small cell carcinoma of the prostate and molecular response to alectinib
Carneiro, B. A., Pamarthy, S., Shah, A. N., Sagar, V., Unno, K., Han, H. Y., Yang, X. J., Costa, R. B., Nagy, R. J., Lanman, R. B., Kuzel, T. M., Ross, J. S., Gay, L., Elvin, J. A., Ali, S. M., Cristofanilli, M., Chae, Y. K., Giles, F. J. & Abdulkadir, S. A., Jun 15 2018, In : Clinical Cancer Research. 24, 12, p. 2732-2739 8 p.Research output: Contribution to journal › Article
Small Cell Carcinoma
Prostate
Mutation
Organoids
Prostatic Neoplasms